Teva Pharmaceuticals - Wikipedia
Teva sells Paragard to CooperSurgical for $1.1B - Philadelphia Business Journal
Generic medicines
KLC Advises Teva on Greek Manufacturing Site Divestment to PharmaPath
Specialty Medicines
PharmaBoardroom - TEVA
Teva Pharmaceuticals forms global specialty medicines group - Philadelphia Business Journal
New Report Shows Teva Generic Medicines Saved US Healthcare System $41.9 Billion | BioSpace
Hungry for brand sales, Teva undercuts generics with new, $60K Huntington's med Austedo | Fierce Pharma
Teva's Respiratory Drugs Contribute 11% to Specialty Medicines
New York takes Teva, McKesson, others to trial over opioids | Business Insurance
Insights on Teva's acquisition of Allergan Generics | Packaging World
Transitioning Teva revamps branding to emphasize brand-generic unity | Fierce Pharma
Complex generics will boost speciality biz, Teva says
Allergan sells generic drug unit to Israel's Teva for $40.5 billion - Los Angeles Times
Teva Announces Sale of Remaining Assets in Specialty Global Women's Health Portfolio for $1.38 Billion – Sawaya Partners., LLC
Company Facts & Figures
Teva Pharmaceutical CEO says health-care is facing 'huge disruption'
Teva Generic Medicines Saved the United States $28.8 Billion in 2020, and a Total of $43.1 Billion Across Major Markets, According to Independent Analysis | Business Wire
Teva Pharmaceuticals | LinkedIn
Teva Pharmaceuticals | LinkedIn
Central Nervous System Is Key to Teva's Specialty Medicines
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
